Smith & Nephew Offers New Post-Operative Dressing

       Smith & Nephew Wound Management introduces ACTICOAT* Post-Op, a silver-coated antimicrobial barrier dressing designed to help manage infection risk following cardiothoracic, orthopedic, soft tissue, and other surgical procedures.
       ACTICOAT Post-Op is a unique tri-laminate dressing consisting of a proprietary perforated nanocrystalline silver wound contact layer; an absorbent hydrocellular foam layer; and a transparent, waterproof adhesive top film (IV 3000*). It provides bactericidal activity to protect against exogenous and endogenous bacterial infection. The dressing also provides excellent absorption and can be left in place for up to seven days, providing continuous antimicrobial activity while potentially reducing costs associated with multiple dressing changes.
       As the newest member of the ACTICOAT family of silver-coated antimicrobial barrier dressings, ACTICOAT Post-Op is formulated with SILCRYST* nanocrystalline silver technology, which explains its potent, fast-acting, and long-lasting bactericidal properties. ACTICOAT offers potent bactericidal activity against multiple strains of methicillin-resistant Staphylococcus aureus (MRSA) and other pathogens that cause increasing concern in the postoperative patient.
       The launch of ACTICOAT Post-Op expands Smith & Nephew’s portfolio of infection management products, which includes ACTICOAT 3-day and 7-day, Absorbent, Moisture Control, and Site (for percutaneous insertion sites) as well as IODOSORB* and IODOFLEX*, two bactericidal and noncytotoxic cadexomer iodine-based wound care products.
       For more information, call 800-876-1261 or visit www.smith-nephew.com.

Geritrex Expands Line of Unit-Dose Products

       Geritrex Corporation, a leading manufacturer of branded generic over-the-counter healthcare products since 1978, has expanded its unit-dose lines with the addition of three new products. The additional products, which are formulated for internal or external use as needed, consist of Sorbitol 30 mL and two ointments—bacitracin and triple antibiotic.
       Each dose is bar-coded as specified by Food and Drug Administration (FDA) guidelines and features an easy-open design that makes it simple to administer as well. Economically priced, Sorbitol 30 mL complies with all applicable Joint Commission (JCAHO) standards and is packaged in 40-unit doses with master cases holding six boxes per case. The bacitracin and triple antibiotic ointments (for external use only) meet FDA and JCAHO standards. The products were specially designed to meet the needs of hospitals, nursing homes, and similar institutions.
       Geritrex also recently introduced Mineral Freez Gel^TM, a product that provides a cooling icy sensation followed by warmth to deep muscles.
       For free samples and/or more information, visit www.geritrex.com or call 800-736-3437.

MedEfficiency Introduces Total Contact Cast System

       Offloading is an important but often overlooked element in the management of patients with diabetic foot ulcers. The total contact cast (TCC), long considered the gold standard in diabetic foot off-loading, provides a dynamic approach to complete immobilization, which allows the tissue to heal without being disturbed or traumatized by repetitive injury. The TCC provides a treatment modality that creates round-the-clock patient compliance but still allows for patient ambulation. The TCC is changed on a periodic basis to address the dynamic nature of the patient’s lower extremity and for wound inspection/debridement.
       MedEfficiency, Inc., aims to make the gold standard an easier clinical option with the introduction of the TCC-EZ Total Contact Cast System. It provides an innovative fishnet mesh cast technology to construct a one-layered cast supported by an exclusively designed outer shell that provides additional support and stability to the patient. The TCC-EZ is faster and easier to apply than the traditional Total Contact Cast System and other TCCs. MedEfficiency provides training courses that ensure proper application techniques and review of the indications/contraindications and standardized protocols.
       For more information, call 866-357-7755 or visit www.MedEfficiency.com.